These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2662334)

  • 1. Early detection of gynecologic malignancies.
    Weed JC; Marine CS
    Semin Surg Oncol; 1989; 5(3):176-8. PubMed ID: 2662334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening in gynecologic cancers.
    Averette HE; Steren A; Nguyen HN
    Cancer; 1993 Aug; 72(3 Suppl):1043-9. PubMed ID: 8392908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the cancer marker CA 125 in gynecologic diseases].
    Pilgrim G; von Broen B; Johannsmeyer KD
    Z Gesamte Inn Med; 1989 Apr; 44(8):251-4. PubMed ID: 2741520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of Papanicolaou test in gynecologic practice].
    Grio R; Piacentino R; Ferrara L; Condello V; Fuda G; Caccuri D; Giobbe C; Marchino GL
    Minerva Ginecol; 1991 Sep; 43(9):393-4. PubMed ID: 1945026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA 125 levels in benign and malignant gynecologic diseases.
    Hsieh CY; Hsu HC; Huang SC; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1988 Jun; 87(6):641-6. PubMed ID: 3171529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic value of detecting CA-125 antigen in patients with gynecologic diseases].
    Adamian LV; Alekseeva ML; Andreeva EN; Novikov EA; Fanchenko ND
    Akush Ginekol (Mosk); 1990 Dec; (12):57-8. PubMed ID: 2090002
    [No Abstract]   [Full Text] [Related]  

  • 7. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological tumor].
    Shigemasa K; Hiura M; Ioka A; Yokoyama T; Nogawa T; Chiba T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):256-7. PubMed ID: 8492013
    [No Abstract]   [Full Text] [Related]  

  • 9. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic cancer. Pathology and methods of screening.
    Trott PA
    Nurs Mirror Midwives J; 1976 Sep; 143(11):46-8. PubMed ID: 1049066
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
    Nozawa S; Udagawa Y; Ohkura H; Negishi Y; Akiya K; Inaba N; Takamizawa H; Kimura E; Terashima Y
    Clin Chim Acta; 1990 Jan; 186(2):275-84. PubMed ID: 2178810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphometric analysis of the normal, dyskaryotic and cancerous cells in gynecological smears].
    Kasabova M
    Akush Ginekol (Sofiia); 1984; 23(6):510-5. PubMed ID: 6532230
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening and early diagnosis of gynecologic cancers.
    Warner EA; Parsons AK
    Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of tumor markers in the management of patients with gynecologic carcinomas.
    Berchuck A; Boente MP; Bast RC
    Clin Obstet Gynecol; 1992 Mar; 35(1):45-54. PubMed ID: 1544249
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
    Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography application for gynecologic tumors.
    Nakamoto Y; Saga T; Fujii S
    Int J Gynecol Cancer; 2005; 15(5):701-9. PubMed ID: 16174216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Features of Uncommon Gynecologic Cancers.
    Miccò M; Sala E; Lakhman Y; Hricak H; Vargas HA
    AJR Am J Roentgenol; 2015 Dec; 205(6):1346-59. PubMed ID: 26587944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis of gynecologic neoplasms with special reference to the possibilities of a general physician].
    Marsch F
    Z Allgemeinmed; 1971 Apr; 47(11):577-8. PubMed ID: 5553244
    [No Abstract]   [Full Text] [Related]  

  • 19. Less common gynecologic malignancies.
    Door A
    Semin Oncol Nurs; 2002 Aug; 18(3):207-22. PubMed ID: 12184044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for gynecologic cancers.
    Rosenthal AN
    Curr Opin Oncol; 1998 Sep; 10(5):447-51. PubMed ID: 9800116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.